List of Tables
Table 1. Global Sartan-series Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Losartan
Table 3. Key Players of Valsartan
Table 4. Key Players of Irbesartan
Table 5. Key Players of Telmisartan
Table 6. Key Players of Olmesartan
Table 7. Key Players of Candesartan
Table 8. Key Players of Sacubitril/valsartan
Table 9. Global Sartan-series Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 10. Global Sartan-series Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 11. Global Sartan-series Drugs Market Size by Region (US$ Million), 2021–2026
Table 12. Global Sartan-series Drugs Market Share by Region (2021–2026)
Table 13. Global Sartan-series Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
Table 14. Global Sartan-series Drugs Market Share by Region (2027–2032)
Table 15. Sartan-series Drugs Market Trends
Table 16. Sartan-series Drugs Market Drivers
Table 17. Sartan-series Drugs Market Challenges
Table 18. Sartan-series Drugs Market Restraints
Table 19. Global Sartan-series Drugs Revenue by Players (US$ Million), 2021–2026
Table 20. Global Sartan-series Drugs Market Share by Players (2021–2026)
Table 21. Global Top Sartan-series Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Sartan-series Drugs Revenue, 2025
Table 22. Ranking of Global Top Sartan-series Drugs Companies by Revenue (US$ Million) in 2025
Table 23. Global 5 Largest Players Market Share by Sartan-series Drugs Revenue (CR5 and HHI), 2021–2026
Table 24. Global Key Players of Sartan-series Drugs, Headquarters and Area Served
Table 25. Global Key Players of Sartan-series Drugs, Products and Applications
Table 26. Global Key Players of Sartan-series Drugs, Date of General Availability (GA)
Table 27. Mergers and Acquisitions, Expansion Plans
Table 28. Global Sartan-series Drugs Market Size by Type (US$ Million), 2021–2026
Table 29. Global Sartan-series Drugs Revenue Market Share by Type (2021–2026)
Table 30. Global Sartan-series Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
Table 31. Global Sartan-series Drugs Revenue Market Share by Type (2027–2032)
Table 32. Global Sartan-series Drugs Market Size by Application (US$ Million), 2021–2026
Table 33. Global Sartan-series Drugs Revenue Market Share by Application (2021–2026)
Table 34. Global Sartan-series Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
Table 35. Global Sartan-series Drugs Revenue Market Share by Application (2027–2032)
Table 36. North America Sartan-series Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. North America Sartan-series Drugs Market Size by Country (US$ Million), 2021–2026
Table 38. North America Sartan-series Drugs Market Size by Country (US$ Million), 2027–2032
Table 39. Europe Sartan-series Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 40. Europe Sartan-series Drugs Market Size by Country (US$ Million), 2021–2026
Table 41. Europe Sartan-series Drugs Market Size by Country (US$ Million), 2027–2032
Table 42. Asia-Pacific Sartan-series Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 43. Asia-Pacific Sartan-series Drugs Market Size by Region (US$ Million), 2021–2026
Table 44. Asia-Pacific Sartan-series Drugs Market Size by Region (US$ Million), 2027–2032
Table 45. Latin America Sartan-series Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Latin America Sartan-series Drugs Market Size by Country (US$ Million), 2021–2026
Table 47. Latin America Sartan-series Drugs Market Size by Country (US$ Million), 2027–2032
Table 48. Middle East & Africa Sartan-series Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 49. Middle East & Africa Sartan-series Drugs Market Size by Country (US$ Million), 2021–2026
Table 50. Middle East & Africa Sartan-series Drugs Market Size by Country (US$ Million), 2027–2032
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis Sartan-series Drugs Product
Table 54. Novartis Revenue in Sartan-series Drugs Business (US$ Million), 2021–2026
Table 55. Novartis Recent Development
Table 56. Merck & Co Company Details
Table 57. Merck & Co Business Overview
Table 58. Merck & Co Sartan-series Drugs Product
Table 59. Merck & Co Revenue in Sartan-series Drugs Business (US$ Million), 2021–2026
Table 60. Merck & Co Recent Development
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Sartan-series Drugs Product
Table 64. Sanofi Revenue in Sartan-series Drugs Business (US$ Million), 2021–2026
Table 65. Sanofi Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Sartan-series Drugs Product
Table 69. Pfizer Revenue in Sartan-series Drugs Business (US$ Million), 2021–2026
Table 70. Pfizer Recent Development
Table 71. Bayer Company Details
Table 72. Bayer Business Overview
Table 73. Bayer Sartan-series Drugs Product
Table 74. Bayer Revenue in Sartan-series Drugs Business (US$ Million), 2021–2026
Table 75. Bayer Recent Development
Table 76. AstraZeneca Company Details
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Sartan-series Drugs Product
Table 79. AstraZeneca Revenue in Sartan-series Drugs Business (US$ Million), 2021–2026
Table 80. AstraZeneca Recent Development
Table 81. Daiichi Sankyo Company Details
Table 82. Daiichi Sankyo Business Overview
Table 83. Daiichi Sankyo Sartan-series Drugs Product
Table 84. Daiichi Sankyo Revenue in Sartan-series Drugs Business (US$ Million), 2021–2026
Table 85. Daiichi Sankyo Recent Development
Table 86. Takeda Company Details
Table 87. Takeda Business Overview
Table 88. Takeda Sartan-series Drugs Product
Table 89. Takeda Revenue in Sartan-series Drugs Business (US$ Million), 2021–2026
Table 90. Takeda Recent Development
Table 91. Bristol-Myers Squibb Company Company Details
Table 92. Bristol-Myers Squibb Company Business Overview
Table 93. Bristol-Myers Squibb Company Sartan-series Drugs Product
Table 94. Bristol-Myers Squibb Company Revenue in Sartan-series Drugs Business (US$ Million), 2021–2026
Table 95. Bristol-Myers Squibb Company Recent Development
Table 96. Boehringer Ingelheim Company Details
Table 97. Boehringer Ingelheim Business Overview
Table 98. Boehringer Ingelheim Sartan-series Drugs Product
Table 99. Boehringer Ingelheim Revenue in Sartan-series Drugs Business (US$ Million), 2021–2026
Table 100. Boehringer Ingelheim Recent Development
Table 101. Abbott Company Details
Table 102. Abbott Business Overview
Table 103. Abbott Sartan-series Drugs Product
Table 104. Abbott Revenue in Sartan-series Drugs Business (US$ Million), 2021–2026
Table 105. Abbott Recent Development
Table 106. Teva Pharmaceutical Company Details
Table 107. Teva Pharmaceutical Business Overview
Table 108. Teva Pharmaceutical Sartan-series Drugs Product
Table 109. Teva Pharmaceutical Revenue in Sartan-series Drugs Business (US$ Million), 2021–2026
Table 110. Teva Pharmaceutical Recent Development
Table 111. Shenzhen Salubris Pharmaceuticals Company Details
Table 112. Shenzhen Salubris Pharmaceuticals Business Overview
Table 113. Shenzhen Salubris Pharmaceuticals Sartan-series Drugs Product
Table 114. Shenzhen Salubris Pharmaceuticals Revenue in Sartan-series Drugs Business (US$ Million), 2021–2026
Table 115. Shenzhen Salubris Pharmaceuticals Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Sartan-series Drugs Picture
Figure 2. Global Sartan-series Drugs Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Sartan-series Drugs Market Share by Type: 2025 vs 2032
Figure 4. Losartan Features
Figure 5. Valsartan Features
Figure 6. Irbesartan Features
Figure 7. Telmisartan Features
Figure 8. Olmesartan Features
Figure 9. Candesartan Features
Figure 10. Sacubitril/valsartan Features
Figure 11. Others Features
Figure 12. Global Sartan-series Drugs Market Size by Application (US$ Million), 2021–2032
Figure 13. Global Sartan-series Drugs Market Share by Application: 2025 vs 2032
Figure 14. Hospital Pharmaty Case Studies
Figure 15. Retail Pharmacy Case Studies
Figure 16. Sartan-series Drugs Report Years Considered
Figure 17. Global Sartan-series Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 18. Global Sartan-series Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Sartan-series Drugs Market Share by Region: 2025 vs 2032
Figure 20. Global Sartan-series Drugs Market Share by Players in 2025
Figure 21. Global Sartan-series Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. The Top 10 and 5 Players Market Share by Sartan-series Drugs Revenue in 2025
Figure 23. North America Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. North America Sartan-series Drugs Market Share by Country (2021–2032)
Figure 25. United States Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Canada Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Europe Sartan-series Drugs Market Share by Country (2021–2032)
Figure 29. Germany Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. France Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. U.K. Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Italy Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Russia Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Ireland Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Asia-Pacific Sartan-series Drugs Market Share by Region (2021–2032)
Figure 37. China Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Japan Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. South Korea Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Southeast Asia Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. India Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Australia & New Zealand Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Latin America Sartan-series Drugs Market Share by Country (2021–2032)
Figure 45. Mexico Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Brazil Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Middle East & Africa Sartan-series Drugs Market Share by Country (2021–2032)
Figure 49. Israel Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Saudi Arabia Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. UAE Sartan-series Drugs Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Novartis Revenue Growth Rate in Sartan-series Drugs Business (2021–2026)
Figure 53. Merck & Co Revenue Growth Rate in Sartan-series Drugs Business (2021–2026)
Figure 54. Sanofi Revenue Growth Rate in Sartan-series Drugs Business (2021–2026)
Figure 55. Pfizer Revenue Growth Rate in Sartan-series Drugs Business (2021–2026)
Figure 56. Bayer Revenue Growth Rate in Sartan-series Drugs Business (2021–2026)
Figure 57. AstraZeneca Revenue Growth Rate in Sartan-series Drugs Business (2021–2026)
Figure 58. Daiichi Sankyo Revenue Growth Rate in Sartan-series Drugs Business (2021–2026)
Figure 59. Takeda Revenue Growth Rate in Sartan-series Drugs Business (2021–2026)
Figure 60. Bristol-Myers Squibb Company Revenue Growth Rate in Sartan-series Drugs Business (2021–2026)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in Sartan-series Drugs Business (2021–2026)
Figure 62. Abbott Revenue Growth Rate in Sartan-series Drugs Business (2021–2026)
Figure 63. Teva Pharmaceutical Revenue Growth Rate in Sartan-series Drugs Business (2021–2026)
Figure 64. Shenzhen Salubris Pharmaceuticals Revenue Growth Rate in Sartan-series Drugs Business (2021–2026)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
